COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey

Affiliations

¹ Department of Precision and Translational Medicine, Sapienza University, Rome, Italy. breccia@bce.uniroma1.it.
² GIMEMA Foundation, Rome, Italy.
³ Department of Radiological and Hematological Sciences, Section of Hematology, Catholic University, Fondazione Policlinico A. Gemelli IRCSS, Rome, Italy.
⁴ Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
⁵ Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
⁶ Hematology Unit, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy.
⁷ Institute of Hematology "L. and A. Seràgnoli", St. Orsola-Malpighi University Hospital, Bologna, Italy.
⁸ Haematology Unit, Department PROMISE, University of Palermo, Palermo, Italy.
⁹ Department of Emergency and Organ Transplantation (D.E.T.O.), Hematology Section, University of Bari, Bari, Italy.
¹⁰ Division of Hematology, Department of Medicine and Surgery, Ospedale di Circolo, University of Insubria, ASST Sette Laghi, Varese, Italy.
¹¹ Department of Precision and Translational Medicine, Sapienza University, Rome, Italy.
¹² CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy.

Massimo Breccia et al. Leukemia. 2020 Oct.

. 2020 Oct;34(10):2813-2814.

doi: 10.1038/s41375-020-01032-0. Epub 2020 Aug 25.

¹ Department of Precision and Translational Medicine, Sapienza University, Rome, Italy. breccia@bce.uniroma1.it.
² GIMEMA Foundation, Rome, Italy.
³ Department of Radiological and Hematological Sciences, Section of Hematology, Catholic University, Fondazione Policlinico A. Gemelli IRCSS, Rome, Italy.
⁴ Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
⁵ Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
⁶ Hematology Unit, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy.
⁷ Institute of Hematology "L. and A. Seràgnoli", St. Orsola-Malpighi University Hospital, Bologna, Italy.
⁸ Haematology Unit, Department PROMISE, University of Palermo, Palermo, Italy.
⁹ Department of Emergency and Organ Transplantation (D.E.T.O.), Hematology Section, University of Bari, Bari, Italy.
¹⁰ Division of Hematology, Department of Medicine and Surgery, Ospedale di Circolo, University of Insubria, ASST Sette Laghi, Varese, Italy.
¹¹ Department of Precision and Translational Medicine, Sapienza University, Rome, Italy.
¹² CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy.

No abstract available

Conflict of interest statement

The authors declare that they have no conflict of interest.

1. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335–7. - PMC - PubMed
1. Xia Y, Jin R, Zhao J, Li W, Shen H. Risk of COVID-19 for patients with cancer. Lancet Oncol. 2020;21:e180. - PMC - PubMed
1. Wang H, Zhang L. Risk of COVID-19 for patients with cancer. Lancet Oncol. 2020;21:e181. - PMC - PubMed
1. He W, Chen L, Chen L, Yuan G, Fang Y, Chen W, et al. COVID-19 in persons with haematological cancers. Leukemia. 2020;24:1–9. - PMC - PubMed
1. Li W, Wang D, Guo J, Yuan G, Yang Z, Gale RP, et al. COVID-19 in persons with chronic myeloid leukaemia. Leukemia. 2020;34:1799–804. - PMC - PubMed